This trial is testing a possible treatment for lung cancer that involves two drugs.
3 Primary · 3 Secondary · Reporting Duration: 2 years
Experimental Treatment
72 Total Participants · 4 Treatment Groups
Primary Treatment: Palbociclib · No Placebo Group · Phase 1 & 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: